IL-2 and IL-15 manifest opposing effects on activation of nuclear factor of activated T cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cellular Immunology

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0008-8749(03)00168-0PMID 14527511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oligomerization of IL-2Ralpha.

  2002cited by this paper
• OLIGOMERIZATION OF IL-2Rα

  2002cited by this paper
• Molecular mechanisms of activated T cell death in vivo.

  2002cited by this paper
• Control of homeostasis of CD8+ memory T cells by opposing cytokines.

  2000cited by this paper
• FasL promoter activation by IL‐2 through SP1 and NFAT but not Egr‐2 and Egr‐3

  1999cited by this paper
• Recognition of NFATp/AP-1 composite elements within genes induced upon the activation of immune cells.

  1999cited by this paper
• T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death.

  1998cited by this paper
• Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development.

  1998cited by this paper
• The transcription factor NFAT4 is involved in the generation and survival of T cells.

  1998cited by this paper
• Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis.

  1998cited by this paper
• The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production.

  1998cited by this paper
• IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

  1998cited by this paper
• Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc.

  1998cited by this paper
• IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling.

  1998cited by this paper
• IL-2Rα on One Cell Can Present IL-2 to IL-2Rβ/γc on Another Cell to Augment IL-2 Signaling

  1998cited by this paper
• Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor

  1997cited by this paper
• Transcription factors of the NFAT family: regulation and function.

  1997cited by this paper
• Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.

  1997cited by this paper
• An Enhanced Immune Response in Mice Lacking the Transcription Factor NFAT1

  1996cited by this paper
• Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice.

  1996cited by this paper
• Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

  1996cited by this paper
• Interleukin‐15 up‐regulates interleukin‐2 receptor α chain but down‐regulates its own high‐affinity binding sites on human T and B cells

  1996cited by this paper
• Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A.

  1996cited by this paper
• Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes.

  1995cited by this paper
• Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.

  1995cited by this paper
• Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.

  1995cited by this paper
• Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2

  1994cited by this paper
• Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

  1994cited by this paper
• Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells

  1994cited by this paper
• Controlling signal transduction with synthetic ligands.

  1993cited by this paper
• lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis

  1991cited by this paper
• Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

  1991cited by this paper
• The interleukin-2 receptor.

  1991cited by this paper
• Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

  1991cited by this paper
• Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis.

  1988cited by this paper
• SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

  1988cited by this paper

• Crohn's disease alters MHC‐rafts in CD4+ T‐cells

  2012cites this paper
• The role of IL‐15 in central nervous system disorders

  2012cites this paper
• Blockade of IL‐15 activity inhibits microglial activation through the NFκB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release

  2010cites this paper
• IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.

  2009cites this paper
• L-2 signaling prevents T cell anergy by inhibiting the expression of nergy-inducing genes

  2008cites this paper
• Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin‐15

  2006cites this paper
• Cytokine modulation of defensive rage behavior in the cat: role of GABAA and interleukin-2 receptors in the medial hypothalamus.

  2005cites this paper
• Interleukin (IL)-15 and IL-2 Reciprocally Regulate Expression of the Chemokine Receptor CX3CR1 through Selective NFAT1- and NFAT2-dependent Mechanisms*

  2004cites this paper